BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26059697)

  • 1. A non-randomized confirmatory study regarding selection of fertility-sparing surgery for patients with epithelial ovarian cancer: Japan Clinical Oncology Group Study (JCOG1203).
    Satoh T; Tsuda H; Kanato K; Nakamura K; Shibata T; Takano M; Baba T; Ishikawa M; Ushijima K; Yaegashi N; Yoshikawa H;
    Jpn J Clin Oncol; 2015 Jun; 45(6):595-9. PubMed ID: 26059697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fertility-sparing surgery for early stage epithelial ovarian cancer.
    Satoh T; Yoshikawa H
    Jpn J Clin Oncol; 2016 Aug; 46(8):703-10. PubMed ID: 27284094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Methods and conditions of fertility preservation in early-stage ovarian tumors].
    Szatmári E; Máté S; Sipos N; Szánthó A; Silhavy M; Rigó J
    Orv Hetil; 2013 Apr; 154(14):523-30. PubMed ID: 23545230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin/paclitaxel chemotherapy: a single institution experience.
    Bamias A; Karadimou A; Soupos N; Sotiropoulou M; Zagouri F; Haidopoulos D; Thomakos N; Rodolakis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2011 Oct; 123(1):37-42. PubMed ID: 21764430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncofertility in patients with stage I epithelial ovarian cancer: fertility-sparing surgery in young women of reproductive age.
    Jiang X; Yang J; Yu M; Xie W; Cao D; Wu M; Pan L; Huang H; You Y; Shen K
    World J Surg Oncol; 2017 Aug; 15(1):154. PubMed ID: 28806962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All-Cause Mortality After Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer.
    Melamed A; Rizzo AE; Nitecki R; Gockley AA; Bregar AJ; Schorge JO; Del Carmen MG; Rauh-Hain JA
    Obstet Gynecol; 2017 Jul; 130(1):71-79. PubMed ID: 28594773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection.
    Satoh T; Hatae M; Watanabe Y; Yaegashi N; Ishiko O; Kodama S; Yamaguchi S; Ochiai K; Takano M; Yokota H; Kawakami Y; Nishimura S; Ogishima D; Nakagawa S; Kobayashi H; Shiozawa T; Nakanishi T; Kamura T; Konishi I; Yoshikawa H
    J Clin Oncol; 2010 Apr; 28(10):1727-32. PubMed ID: 20194858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy.
    Schilder JM; Thompson AM; DePriest PD; Ueland FR; Cibull ML; Kryscio RJ; Modesitt SC; Lu KH; Geisler JP; Higgins RV; Magtibay PM; Cohn DE; Powell MA; Chu C; Stehman FB; van Nagell J
    Gynecol Oncol; 2002 Oct; 87(1):1-7. PubMed ID: 12468335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fertility-sparing surgery for young women with early-stage epithelial ovarian cancer.
    Nam JH; Park JY
    Gynecol Obstet Invest; 2013; 76(1):14-24. PubMed ID: 23751891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous/intraperitoneal paclitaxel and intraperitoneal carboplatin in patients with epithelial ovarian, fallopian tube, or peritoneal carcinoma: a feasibility study.
    Nagao S; Iwasa N; Kurosaki A; Nishikawa T; Ohishi R; Hasegawa K; Goto T; Fujiwara K
    Int J Gynecol Cancer; 2012 Jan; 22(1):70-5. PubMed ID: 22146766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservative fertility-sparing surgical treatment of invasive epithelial ovarian cancer: when is it acceptable?
    Menczer J
    Isr Med Assoc J; 2013 Feb; 15(2):116-20. PubMed ID: 23516776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fertility sparing surgery in early stage epithelial ovarian cancer.
    Ditto A; Martinelli F; Lorusso D; Haeusler E; Carcangiu M; Raspagliesi F
    J Gynecol Oncol; 2014 Oct; 25(4):320-7. PubMed ID: 25142621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term survival after fertility-sparing surgery for epithelial ovarian cancer.
    Schlaerth AC; Chi DS; Poynor EA; Barakat RR; Brown CL
    Int J Gynecol Cancer; 2009 Oct; 19(7):1199-204. PubMed ID: 19823055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel directions in adjuvant chemotherapy for early stage epithelial ovarian cancer.
    Sakarya DK; Yetimalar MH; Ozbasar D
    Asian Pac J Cancer Prev; 2015; 16(10):4157-60. PubMed ID: 26028065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of laparoscopic fertility-sparing surgery in clinically early-stage epithelial ovarian cancer.
    Park JY; Heo EJ; Lee JW; Lee YY; Kim TJ; Kim BG; Bae DS
    J Gynecol Oncol; 2016 Mar; 27(2):e20. PubMed ID: 26768783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of staging surgery and adjuvant chemotherapy in adult patients with apparent stage I pure immature ovarian teratoma after fertility-sparing surgery.
    Wang D; Zhu S; Jia C; Cao D; Wu M; Shen K; Yang J; Xiang Y
    Int J Gynecol Cancer; 2020 May; 30(5):664-669. PubMed ID: 32179695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: Safety and effectiveness.
    da Costa Miranda V; de Souza Fêde ÂB; Dos Anjos CH; da Silva JR; Sanchez FB; da Silva Bessa LR; de Paula Carvalho J; Filho EA; de Freitas D; Del Pilar Estevez Diz M
    Gynecol Oncol; 2014 Feb; 132(2):287-91. PubMed ID: 24333355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathology predicts clinical outcome in advanced epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and debulking surgery.
    Muraji M; Sudo T; Iwasaki S; Ueno S; Wakahashi S; Yamaguchi S; Fujiwara K; Nishimura R
    Gynecol Oncol; 2013 Dec; 131(3):531-4. PubMed ID: 24096109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservative management of epithelial ovarian cancer.
    Dexeus S; Labastida R; Dexeus D
    Eur J Gynaecol Oncol; 2005; 26(5):473-8. PubMed ID: 16285560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of complete surgical staging with pelvic and para-aortic lymphadenectomy and paclitaxel plus carboplatin chemotherapy for improvement of survival in stage I ovarian clear cell carcinoma.
    Ho CM; Chien TY; Shih BY; Huang SH
    Gynecol Oncol; 2003 Mar; 88(3):394-9. PubMed ID: 12648592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.